Regent Pacific Group (STU:RPG) Moat Score: 3/10 (As of Jul. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:RPG Regent Pacific Group Ltd STU:RPG
16 GF Score
Price €0.10
GF Value €0.05
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Regent Pacific Group Moat Score?

Regent Pacific Group STU:RPG +6.19% 16 Moat Score is 3 as of Jul. 15, 2026. GuruFocus rates STU:RPG with a GF Score™ of 16/100 and a GF Value™ of €0.05 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 1,031 Drug Manufacturers companies, Regent Pacific Group ranks better than 86.03% on this metric.

Regent Pacific Group has the Moat Score of 3, which implies that the company might have No Moat - Very weak/transient advantages.

Regent Pacific Group has No Moat: Regent Pacific Group Ltd shows very weak competitive advantages with limited market leadership and no significant intellectual property or cost advantages.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Regent Pacific Group might have No Moat - Very weak/transient advantages.

Regent Pacific Group  (STU:RPG) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Regent Pacific Group Moat Score Related Terms

STU:RPG vs ZTS, UTHR: Moat Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Regent Pacific Group's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Regent Pacific Group Moat Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Regent Pacific Group's Moat Score distribution charts can be found below:

* The bar in red indicates where Regent Pacific Group's Moat Score falls into.


STU:RPG
16GF Score
Regent Pacific Group Ltd STU:RPG
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 3 mean?
Regent Pacific Group (STU:RPG) has a Moat Score of 3 as of Jul. 15, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Regent Pacific Group ranks #144 out of 1031 companies in the Drug Manufacturers industry, placing it in the top 14%.
Is Regent Pacific Group's Moat Score too high?
Regent Pacific Group's current Moat Score is 3. Based on the distribution chart, Regent Pacific Group ranks #144 out of 1031 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Regent Pacific Group has a GF Score™ of 16/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Regent Pacific Group's Moat Score compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Regent Pacific Group ranks #144 out of 1031 companies for Moat Score. This places Regent Pacific Group in the top 14% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Drug Manufacturers company?
A good Moat Score depends on the Drug Manufacturers industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Regent Pacific Group's current Moat Score is 3. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Regent Pacific Group stock overvalued right now?
Based on GuruFocus' analysis, Regent Pacific Group (STU:RPG) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.05, compared to a current price of €0.10 — trading 106% above its estimated fair value. The current Moat Score is 3. Regent Pacific Group's overall GF Score™ is 16/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Regent Pacific Group (STU:RPG), the current Moat Score is 3 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Regent Pacific Group (STU:RPG) Overvalued in 2026?

Based on GuruFocus' analysis, Regent Pacific Group stock appears to be overvalued. The current stock price of €0.10 is trading 106% above its estimated GF Value™ of €0.05. GuruFocus considers Regent Pacific Group to be Significantly Overvalued.

Key valuation signals for STU:RPG:

  • Moat Score: 3
  • GF Value™: €0.05 vs. price of €0.10 (106% above fair value)
  • GF Score™: 16/100 with 7 warning signs

No single metric tells the full story. See the STU:RPG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Regent Pacific Group Business Description

Other Exchanges 00575:Hong Kong
Address 5 Queen\'s Road Central, 8th Floor, Henley Building, Hong Kong, HKG
Regent Pacific Group Ltd is an investment holding company that runs through two segments: Biopharma and Corporate Investment. Its Biopharma segment is engaged in the research, development, manufacturing, marketing, and sales of pharmaceutical products, and it also develops artificial intelligence (AI) systems for the field of biological aging clocks. The Corporate Investment segment is engaged in the investment in listed and unlisted corporate entities. The majority of its revenue comes from the Biopharma segment. Geographically, the Europe; U.S.; and Asia Pacific. It derives maximum revenue from Europe.
16GF Score

Get the complete analysis for STU:RPG

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.10
Price
€0.05
GF Value